Purpose: To study the qualitative and quantitative methods for the investigation of bioÞ lm formation and to examine the correlation between bioÞ lm and antibiotic resistance among the clinical isolates of Acinetobacter baumannii. We also veriÞ ed the association between bioÞ lm and presence of extended spectrum β-lactamases, particularly, bla PER-1 . Methods: A total of 55 isolates were subjected to susceptibility testing by disc diffusion method for 13 clinically relevant antibiotics. Screening for bioÞ lm production was done by both qualitative and quantitative methods through tube and microtitre plate assay respectively. The presence of bla PER-1 was checked by PCR. Results: A. baumannii isolates showed very high resistance (>75%) to imipenem, cephotaxime, amikacin and ciproß oxacin. Only cefoperazone, netillin and norß oxacin were found to be effective agents. Results of microtitre and tube methods were concordant with 34 isolates (62%) showing bioÞ lm formation. Resistance to four antibiotics such as amikacin (82% vs. 17.6%, P<0.001), cephotaxime (88% vs. 11%, P P<0.001), ciproß oxacin (70% vs. 29%, P=0.005) and aztreonam (38% vs. 11%, P=0.039) was comparatively higher among bioÞ lm producers than non-bioÞ lm producers. Microtitre assay additionally detected 14 weakly adherent isolates. Only 11 isolates had bla PER-1 gene and among these two were strong bioÞ lm producers, while remaining were weakly adherent isolates. Conclusion: Microtitre plate method was found to be a more sensitive method for bioÞ lm detection. This study demonstrates a high propensity among the clinical isolates of A. baumannii to form bioÞ lm and a signiÞ cant association of bioÞ lms with multiple drug resistance. Presence of bla PER-1 appears to be more critical for cell adherence than for bioÞ lm formation.
Acinetobacter baumannii has emerged as an important and problematic human pathogen as it is the causative agent of several types of infections including pneumonia, meningitis, septicaemia, and urinary tract infections. It ranked second after Pseudomonas aeruginosa among the nosocomial, aerobic, non-fermentative, gram negative bacilli pathogens.
[1] Furthermore, this organism frequently causes infections associated with medical devices, e.g., vascular catheters, cerebrospinal ß uid shunts, Foley catheters etc. [2] [3] [4] A. baumannii has emerged recently as a major cause of hospital acquired infections because of the extent of its antimicrobial resistance and its propensity to cause large, often multi-facility nosocomial outbreaks. [2] [3] [4] Mortality in patients suffering from A. baumannii infections can be as high as 75%.
[2] Infections due to A. baumannii often prove difÞ cult to treat due to high level of resistance to multiple antibiotics as a result of both intrinsic and acquired mechanisms. [5, 6] The potential ability of A. baumannii to form bioÞ lms might also explain its outstanding antibiotic resistance, survival properties and increased virulence. [2, 6, 7] Indeed one of the recent studies showed a positive correlation between the bioÞ lm formation and presence of extended spectrum of β -lactamase (ESBL) bla PER-1 among the A. baumannii isolates.
[8] A contrary observation was also noticed in yet another study. [9] BioÞ lm formation is a well-known pathogenic mechanism in device related infections in hospitals. [10] Moreover, the environmental survival of some nosocomial pathogens may be facilitated by bioÞ lm formation on abiotic surfaces. Little is known concerning the bioÞ lm formation and its mechanisms in A. baumannii. [7, [11] [12] [13] Therefore, the present study was undertaken on clinical isolates of A. baumannii to determine the frequency of bioÞ lm formation by different methods and correlate bioÞ lm formation with development of multiple antibiotic resistance and ESBL production. Furthermore, we also veriÞ ed existence of any association between bioÞ lm formation and presence of ESBL particularly, bla PER-1 .
Materials and Methods

Bacterial isolates
A total of 55 isolates of A. baumannii in the study were obtained from Pondicherry Institute of Medical Sciences Hospital (PIMS), Puducherry, India, from various clinical specimens like endotracheal aspirates, cerebrospinal ß uid, wound swabs, urine and blood culture specimens from patients admitted in ICUs and acute medical care units during January to April 2007. All the isolates were characterised to the species level using phenotypic tests as described elsewhere. [14, 15] Antimicrobial susceptibility testing was performed for 13 different therapeutically relevant antibiotics by Kirby Bauer disk diffusion method according to norms of Clinical Laboratory Standards Institute (CSLI).
[16] Antibiotics tested included amikacin (10 µg), aztreonam (30 µg), ceftazidime (30 µg), cefotaxime (30 µg), ceftriaxone (30 µg), ciproß oxacin (5 µg), cefepime (30 µg) cefoperazone (30 µg), cefazolin (5 µg), imipenem (10 µg), netillin (30 µg), norß oxacin (30 µg) and oß oxacin (30 µg) which were obtained from Hi-Media, Mumbai.
BioÞ lm production
BioÞ lm formation was checked only for 51 isolates out of 55 isolates. BioÞ lm production was estimated qualitatively for all the isolates by tube method as described previously by Christensen et al.
[17] BioÞ lm production was determined quantitatively using modiÞ ed microtitre plate method described elsewhere.
[18] A. baumannii ATCC 19606 strain was taken as the positive control and a non-bioÞ lm forming bacteria (Escherichia coli strain) as a negative control.
All tests were carried out in triplicates and the results were averaged. In the present study, only strongly adherent ones were taken as bioÞ lm positive while weakly adherent ones were taken as negative for bioÞ lm production.
PCR for bla All isolates of A. baumannii were tested for the presence of bla PER-1 gene by PCR. Detection of bla PER-1 gene was performed using primers that were described in previous investigation.
[8] The PCR reaction mixture (10μL) contained 1μL of reaction buffer (containing 1.5 mM of MgCl2), 50 μM of each deoxyribonucleoside triphosphate, 50 pmol of each PER-1 primer, 0.5U of Taq polymerase (Bangalore Genei) and 30 ng of DNA template. PCR ampliÞ cations were performed using thermocycler (Eppendorf, Germany) with following cycling conditions: (i) initial denaturation step of 5 minutes at 94°C, (ii) 30 cycles of PCR, with each cycle consisting of 30 seconds at 94°C, 30 seconds at 55°C, and 30 seconds at 72°C, and (iii) a Þ nal extension step of 5 minutes at 72°C. PCR end products were analysed on 1.2% agarose gel, stained with ethidium bromide. Statistical analysis was performed wherein categorical variables were compared using the Chi-square test (or Fisher's exact test, if required). Differences were signiÞ cant if the p value associated with the test was < 0.05.
Results
Qualitative tube method of bioÞ lm screening showed 34 isolates (62%) positive for bioÞ lm production. Most of the isolates showed thick blue ring at the liquid-air interface. Some of the isolates showing positive results in tube method are shown in Þ gure 1. In the quantitative assay for the bioÞ lm production, the isolates were classiÞ ed as strongly bioÞ lm producing (strongly adherent), weakly adherent isolates and non-bioÞ lm producers (non-adherent). Quantitative microtitre assay for bioÞ lm formation was strongly positive in 34 isolates (62%) while the remaining isolates were either weakly adherent (14) or non-bioÞ lm producers (3). Fourteen weakly adherent isolates were considered as negative or non-bioÞ lm producers. Both the methods for bioÞ lm detection thus showed similar results. Isolates screened for bioÞ lm formation by microtitre plate assay method are shown in Þ gure 2.
The overall percentage of resistance observed among all the A. baumannii isolates including bioÞ lm producers and bioÞ lm non-producers for 13 antibiotics tested, is given in table 1. A. baumannii isolates showed 100% resistance to imipenem, 89% resistance to cephotaxime, 80% to amikacin and 73% to ciproß oxacin. Cefoperazone and norß oxacin were found to be more effective against most of the isolates. Almost all the multiple antibiotic resistant isolates tested positive for bioÞ lm formation.
The multi-drug resistance patterns of the bioÞ lm producing A. baumannii isolates is shown in table 2. All the bioÞ lm forming isolates showed maximum resistance to imipenem (100%), followed by cephotaxime (88%), amikacin (82%) and ciproß oxacin (70%). Both bioÞ lm producers and non-producers were completely resistant to imipenem. However, resistance to other three antibiotics such as amikacin (82% vs. 17.6%, P <0.001), cephotaxime (88% vs 11%, P<0.001), and ciproß oxacin (70% vs 29%, P=0.005) was comparatively higher among bioÞ lm producers than non-bioÞ lm producers (Table1). Resistance among bioÞ lm producers to aztreonam was also high (38% vs 11%, P=0.039) when compared with non-bioÞ lm producers. Least resistance (5%) was noticed only for cefoperazone. Majority of clinical isolates of A. baumannii, which were isolated from wound infection (44%) showed strong positive results for the bioÞ lm formation. Thirty percent of bioÞ lm producers were from nosocomial pneumonia patients where endotracheal aspirate was the clinical specimen. The third highest number of bioÞ lm producers (12%) were isolated from urinary tract infection. In all remaining sites, the isolation of bioÞ lm producers was less than 6%.
The maximum multiple resistance among the isolates was noticed for antimicrobial agents such as imipenem, cephotaxime, amikacin, cefazolin and ciproß oxacin. Isolates predominantly showed Þ ve unique drug combination proÞ les (Table 2 ). Highest number of isolates (14) showed the proÞ le Ce, Cf, Cz, I, followed by Ak, Ce, Cz, Of, I which had 12 isolates. The resistograms of 13 isolates obtained from different clinical specimens displayed deÞ nite patterns (Table 3) . Isolates collected from patients' endotracheal aspirate showed three distinct proÞ les of resistance namely 1A, 1B, 1C in which a group of nine isolates were resistant to three sets of the same antibiotics. Similarly the isolates from wound infection showed two sets (1C, 2) of unique resistance proÞ les and two of the isolates from urine showed one unique proÞ le.
Presence of bla PER-1 gene was conÞ rmed by detection of DNA fragment of the size 900bp. Eleven isolates showed the presence of bla PER-1 gene, four from respiratory infection, Þ ve from wound infection and one each from traumatic meningitis and urinary tract infection (Fig. 3) . The amplicon size was ~875bp in three of the isolates. Among the 11 bla PER-1 positive isolates, only two showed strong adherence while the remaining nine were weakly adherent. All the 11 bla PER-1 positive isolates were multi-drug resistant and were also resistant to all the β -lactam antibiotics tested. Two bioÞ lm positive isolates (strain ID No. 14 and 28) that were bla PER-1 positive were found to be multi-drug resistant having resistant patterns Ak, Ce, Cf, Ci, Cpm, Cz, I, Nt, Of and Ak, Ce, Cf, I respectively.
Discussion
A. baumannii infections present a global medical challenge. They are opportunistic pathogens and are particularly successful at colonizing and persisting in the hospital environment. They are able to resist desiccation and survive on inanimate surfaces for years. [2] [3] [4] 6] Interest in this organism has been growing rapidly because of the emergence of multi-drug-resistant strains, some of which are pan-resistant to antimicrobial agents. [2, 6, 19] It is also among the most common causes of device-related nosocomial infection that results when the organism is able to resist physical and chemical disinfection, often by forming a bioÞ lm. BioÞ lm formation is thought to be a key pathogenic feature, especially in relation to intravascular line infections and ventilator associated pneumonia. Generally, two properties are often associated with bioÞ lm producing bacteria, namely, the increased synthesis of exopolysaccharide (EPS) and the development of antibiotic resistance.
[20] One can assume that increased production of EPS in A. baumannii is likely to create a protective environment leading to difÞ culty in antibiotic penetration leading to development of resistance. In addition, there appears to be some differences in the cellular physiology of cells within the bioÞ lm that also results in increased drug resistance.
[21] Thus infections due to bacteria that form bioÞ lms are a tenacious clinical problem. Only, few reports have described the ability of clinical isolates of A. baumannii to attach and form bioÞ lms on glass surfaces. [7, 8, 12] We chose to investigate bioÞ lm formation by clinical isolates of A. baumannii and multiple drug resistance among them and tried to correlate them in order to understand how this pathogen persists in the hospital environment and causes outbreaks.
In the present study, both the qualitative and quantitative method showed 34 isolates (62%) as strong bioÞ lm producers. Fourteen isolates, which were weakly adherent, were additionally picked up by the quantitative microtitre assay asserting its sensitiveness. However, as adherence alone may not complete the cycle of process of bioÞ lm formation and there might be many other mechanisms that could explain adherence, [20, 21] we categorised isolates that were weakly adherent as bioÞ lm negative. One of the recent studies [9] had 63% bioÞ lm positive isolates among the 92 studied, which was comparable with our results.
BioÞ lm forming isolates were also less frequently resistant to imipenem and ciproß oxacin in that study [9] while our results showed positive association in bioÞ lm positivity and multiple drug resistance particularly to certain antibiotics. Compared to non-bioÞ lm producers our study also detected signiÞ cantly higher resistance to cephotaxime, amikacin, ciproß oxacin and aztreonam among bioÞ lm producers. Non-bioÞ lm producers showed increased resistance only for netillin and oß oxacin.
Interestingly, it was observed that 44% of isolates (15) among the bioÞ lm positive isolates were isolated from wound infections. These isolates were strongly positive for bioÞ lm. Additionally, 30% of bioÞ lm producers were from pneumonia patients. This indicates that in wound and respiratory infections bioÞ lm may contribute to antibiotic resistance. Appropriate antibiotic selection for the treatment of such bioÞ lm associated infections is extremely important. Carbapenems have been the antibiotics of choice for treatment of infections caused by this organism, but resistance to carbapenems is becoming common, and very few therapeutic options remain. In our study, all the isolates were imipenem resistant which is the most common antibiotic prescribed in this hospital. In addition, high percentage of resistance was also witnessed to cephotaxime, amikacin and ciproß oxacin. The potential ability of A. baumannii to form bioÞ lms could explain this outstanding antibiotic resistance. [7] In concurrence with the other studies [9, 22] we noted that 62% of our isolates that were strong bioÞ lm producers, also showed nearly complete resistance to all the antibiotics tested. Nevertheless, a few of the strong bioÞ lm forming isolates were sensitive to some of the antibacterial agents namely cefoperazone, norß oxacin and netillin. This could be due to the ability of some of these antibiotics to penetrate the bioÞ lms, thereby inhibiting the bacterial growth.
In our study, among the 34 bioÞ lm positive isolates, the resistograms of 13 isolates isolated from different clinical sources like endotracheal aspirate, wound, urine, CSF and blood, displayed distinct patterns (antibiotypes 1A, 1B, 1C, 2, 3). Such antibiotypes imply that the same isolate is being isolated from different patients over a period of time and it also emphasises on persistence and dissemination of A. baumannii in hospital environment. Here, gaining the ability to form bioÞ lm could be a good strategy to enhance the survival and persistence under stressed conditions, e.g. during host invasion or following antibiotic treatment. As a consequence of bioÞ lm development it is said that the ability of Acinetobacter to transfer genes horizontally might also enhance within these micro communities facilitating the spread of antibiotic resistance.
[8] Thus, A. baumannii isolates capable of forming bioÞ lm might be selected under antibiotic pressure, or conversely, A. baumannii might acquire resistance to multiple drugs within bioÞ lm communities. In either case, it appears that the high colonising capacity of A. baumannii, combined with its resistance to multiple drugs, contributes to the organism's survival and further dissemination in the hospital setting. By acquiring various kinds of resistance mechanisms, bioÞ lm phenotype of A. baumannii has developed into one of the most difÞ cult hospital pathogen to control and treat. Nevertheless, not much is known about the mechanism that triggers the development of bioÞ lm in A. baumannii.
Lee et al, [8] have previously reported that there is a strong relationship between bioÞ lm formation and the production of PER-1 β-lactamases. However in our study, only two strong bioÞ lm (strongly adherent) forming isolates were positive for PER-1 β-lactamases. Interestingly, rest of the PER-1 β-lactamase positive isolates (n=9) were weakly adherent or produced negligible bioÞ lm. This observation is in concurrence with the study of Sechi et al, [13] wherein no correlation existed between PER-1 β-lactamase positive isolates and bioÞ lm producers. Nonetheless, these bla PER-1 positive isolates were strongly associated with cell adhesion.
[13] From the above observations, we believe that presence of bla PER-1 is more critical for cell adhesion than for bioÞ lm formation.
Overall, the present study demonstrated a high propensity among the clinical isolates of A. baumannii to form bioÞ lm and there was a signiÞ cant association of bioÞ lms with multiple drug resistance. bla PER-1 presence is likely to facilitate cell adherence. BioÞ lm production in A. baumannii might promote increased colonization and persistence leading to higher rates of device related infections. A greater understanding of the nature of bioÞ lms and intercellular communications within the bioÞ lm and also their role in serious infections of A. baumannii will help in development of new and more effective treatment for Acinetobacter infections.
